RCO

ProPharma Receives 2024 CRO Leadership Award

Retrieved on: 
木曜日, 6月 13, 2024

RALEIGH, N.C., June 13, 2024 /PRNewswire/ -- ProPharma, the world's largest research consulting organization (RCO), a leading global provider of regulatory, clinical, and compliance services for the life sciences industry is pleased to announce it received a 2024 CRO Leadership Award, presented by Clinical Leader. ProPharma is recognized as exceeding expectations in all five of the core categories, which include:

Key Points: 
  • The awards were developed to address struggles in efficiently vetting potential CRO partners.
  • They are based on primary market research from Industry Standard Research (ISR) Reports and presented by Clinical Leader and Life Science Connect.
  • Jason DeGoes, President, ProPharma, said: "It's an incredible honor for ProPharma to be recognized as an industry leader and an example of the hard work, dedication and unwavering attention to excellence by the entire ProPharma team.
  • Strategically positioned in hubs across five continents, ProPharma changes the standard approach to lifecycle development and powers the insights to help companies excel at every stage of the pharmaceutical lifecycle.

Team BlueHalo Demonstrates Integrated Backend Mission Services for Space Force’s SCAR Program

Retrieved on: 
水曜日, 5月 22, 2024

BlueHalo, the prime contractor for the SCAR program, successfully demonstrated the integrated backend mission services to USSF Guardian operators at the 2024 Space Symposium in Colorado Springs, CO. During the demonstration, Guardians received an operator orientation for the SCAR system interface, including the system scheduler and backend mission processor.

Key Points: 
  • BlueHalo, the prime contractor for the SCAR program, successfully demonstrated the integrated backend mission services to USSF Guardian operators at the 2024 Space Symposium in Colorado Springs, CO. During the demonstration, Guardians received an operator orientation for the SCAR system interface, including the system scheduler and backend mission processor.
  • Kratos’ OpenSpace Platform is an important piece of the backend system which will pair with BlueHalo’s BADGER adaptive phased array product to provide multi-beam, multi-orbit mission operations.
  • “The demonstration at the Space Symposium showed vividly how the SCAR Program is leading in the digital transformation of satellite ground systems to become a more dynamic and resilient part of space domain operations,” commented Phil Carrai, President of Kratos’ Space, Training & Cyber Division.
  • “BlueHalo has checked off another milestone for the SCAR program–not only demonstrating the system’s backend mission services and user interface but, most importantly, collecting valuable insight from Guardian operators who will rely on this system for critical space operations,” said Mary Clum, BlueHalo Executive Vice President and Sector President of Labs.

AdaCore Showcase Secure Avionics by Design at CYBERUK

Retrieved on: 
月曜日, 5月 13, 2024

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20240513452617/en/
    AdaCore Showcase Secure Avionics by Design at CYBERUK (Photo: AdaCore UK)
    AdaCore's SAbD technology has emerged from phase 1 of the collaborative and ongoing Edge Avionics programme.
  • Edge Avionics aims to research state-of-the-art systems security by building a real-world demonstrator avionics defense platform (hardware and software) that showcases cyber and battlefield resilience.
  • The Edge Avionics programme is funded by the Rapid Capabilities Office (RCO) of the UK Royal Air Force (UK RAF).
  • A CHERI compute solution provides one of the foundation elements for a secure by design system and is being explored through the Edge Avionics technical demonstrator.

ProPharma Now Certified as Medidata Rave EDC Accredited Partner

Retrieved on: 
木曜日, 4月 18, 2024

RALEIGH, N.C., April 18, 2024 /PRNewswire/ -- ProPharma https://www.propharmagroup.com, the world's largest Research Consulting Organization (RCO), the leading global provider of regulatory, clinical, and compliance services for the life sciences industry, and a portfolio company of Odyssey Investment Partners https://www.odysseyinvestment.com/, today announced that it received accreditation as a CRO partner for Medidata Rave EDC. This milestone marks a significant enhancement in ProPharma's service offering and ability to develop robust, custom electronic data collection systems for clinical research studies. Joining Medidata's industry-leading partner program underscores its commitment to delivering cutting-edge, scalable global solutions throughout the development lifecycle for its Sponsors.

Key Points: 
  • Joining Medidata's industry-leading partner program underscores its commitment to delivering cutting-edge, scalable global solutions throughout the development lifecycle for its Sponsors.
  • "Our certification in Medidata Rave EDC allows ProPharma to provide even greater value to our Sponsor partners by offering these best-in-class solutions with speed, efficiency, accuracy, and cost-effectiveness," said Helen Hall, ProPharma's Global Head of Clinical Data Services.
  • Utilizing various Medidata modules has already positioned ProPharma at the forefront of delivering quality solutions; this new accreditation will further strengthen its capacity to design and implement EDC for our sponsors and will be followed up with further accreditations in other Medidata modules.
  • Our certification in Medidata Rave EDC allows ProPharma to provide even greater value to our Sponsor partners by offering these best-in-class solutions with speed, efficiency, accuracy, and cost-effectiveness as they work to deliver the latest drugs and devices to patients."

BlueHalo Completes USSF SCAR Program Milestone at Space Symposium

Retrieved on: 
木曜日, 4月 18, 2024

COLORADO SPRINGS, Colo., April 18, 2024 /PRNewswire/ -- BlueHalo, the company transforming the future of global defense, today announced the successful completion of a critical milestone for the U.S. Space Force (USSF) Space Rapid Capabilities Office (RCO) Satellite Communication Augmentation Resource (SCAR) program by demonstrating its integrated backend mission services to USSF Guardian operators at the 2024 Space Symposium in Colorado Springs, CO.

Key Points: 
  • COLORADO SPRINGS, Colo., April 18, 2024 /PRNewswire/ -- BlueHalo, the company transforming the future of global defense, today announced the successful completion of a critical milestone for the U.S. Space Force (USSF) Space Rapid Capabilities Office (RCO) Satellite Communication Augmentation Resource (SCAR) program by demonstrating its integrated backend mission services to USSF Guardian operators at the 2024 Space Symposium in Colorado Springs, CO.
    "Amid an increasingly congested and contested space domain, BlueHalo understands that innovation must reach the front lines rapidly," said Jonathan Moneymaker, BlueHalo Chief Executive Officer.
  • The $1.4B Satellite Communication Augmentation Resource (SCAR) program was announced by the USSF Space RCO in May of 2022 to significantly increase satellite control capacity and support their dynamic missions going forward.
  • Last fall, BlueHalo hosted U.S. Space Force officials along with key partners and federal leaders to demonstrate the Company's progress on the SCAR program.
  • With the insight gained from Guardian feedback during the orientation milestone, BlueHalo will integrate the backend mission services into the BADGER Engineering Development Unit (EDU) later this year.

ProPharma Announces Changes to Its Executive Leadership Team

Retrieved on: 
木曜日, 4月 11, 2024

RALEIGH, N.C., April 11, 2024 /PRNewswire/ -- ProPharma, the leading global provider of regulatory, clinical, and compliance services for the life sciences industry and a portfolio company of Odyssey Investment Partners is pleased to announce that it has welcomed Kirk Wroblewski as its new Chief Information Officer (CIO) and Andrew Shaw as General Counsel. In addition, ProPharma has promoted Zosya Popik to Chief Marketing Officer (CMO), previously the Vice President of Global Marketing.

Key Points: 
  • In addition, ProPharma has promoted Zosya Popik to Chief Marketing Officer (CMO), previously the Vice President of Global Marketing.
  • "We are thrilled to welcome Kirk and Andrew to the executive team and to elevate Zosya as our new Chief Marketing Officer," said Mike Stomberg, Chief Executive Officer.
  • "The combined expertise of each of these team members positions ProPharma to transcend in the industry and continue to compete on a global scale."
  • Wroblewski is a highly accomplished, solutions-focused information executive with more than 20 years of experience in healthcare data and analytics.

ProPharma Announces Changes to Its Executive Leadership Team

Retrieved on: 
水曜日, 4月 10, 2024

RALEIGH, N.C., April 10, 2024 /PRNewswire-PRWeb/ -- ProPharma https://www.propharmagroup.com/, the leading global provider of regulatory, clinical, and compliance services for the life sciences industry and a portfolio company of Odyssey Investment Partners https://www.odysseyinvestment.com/ is pleased to announce that it has welcomed Kirk Wroblewski as its new Chief Information Officer (CIO) and Andrew Shaw as General Counsel. In addition, ProPharma has promoted Zosya Popik to Chief Marketing Officer (CMO), previously the Vice President of Global Marketing.

Key Points: 
  • "We're thrilled to welcome Kirk and Andrew to the executive team and to elevate Zosya as our new Chief Marketing Officer," said Mike Stomberg, CEO.
  • "The combined expertise of each of these team members positions ProPharma to transcend in the industry and continue to compete on a global scale."
  • "We are thrilled to welcome Kirk and Andrew to the executive team and to elevate Zosya as our new Chief Marketing Officer," said Mike Stomberg, Chief Executive Officer.
  • "The combined expertise of each of these team members positions ProPharma to transcend in the industry and continue to compete on a global scale."

ProPharma Announces the Appointment of Vicki Gashwiler as Vice President of Clinical Operations, Medical Technology

Retrieved on: 
水曜日, 1月 24, 2024

RALEIGH, N.C., Jan. 24, 2024 /PRNewswire-PRWeb/ -- ProPharma Group (ProPharma), the leading global provider of regulatory, clinical, and compliance services for the life sciences industry, and a portfolio company of Odyssey Investment Partners, today announced the appointment of Vicki Gashwiler as Vice President of Clinical Operations for their Medical Technology organization.

Key Points: 
  • ProPharma Group today announced the appointment of Vicki Gashwiler as Vice President of Clinical Operations for their Medical Technology organization.
  • RALEIGH, N.C., Jan. 24, 2024 /PRNewswire-PRWeb/ -- ProPharma Group (ProPharma), the leading global provider of regulatory, clinical, and compliance services for the life sciences industry, and a portfolio company of Odyssey Investment Partners , today announced the appointment of Vicki Gashwiler as Vice President of Clinical Operations for their Medical Technology organization.
  • Ronald Freeze, ProPharma's Global Head of Medical Technology, said: "I am so excited to have Vicki joining our integrated MedTech team.
  • ProPharma again shows their commitment to the Medical Technology space and the ongoing advancement of its revolutionary Research Consulting Organization (RCO) model with Vicki's appointment as the Vice President of Clinical Operations for Medical Technology.

ProPharma Unveils Prodigy: Groundbreaking Technology-Enabled Consulting Platform to Revolutionize Life Science Consulting Industry

Retrieved on: 
木曜日, 1月 4, 2024

RALEIGH, N.C., Jan. 4, 2024 /PRNewswire-PRWeb/ -- ProPharma Group, the world's largest Research Consulting Organization (RCO) and the leading global provider of regulatory, clinical, and compliance services for the life sciences industry, and a portfolio company of Odyssey Investment Partners, has introduced Prodigy, an end-to-end technology-enabled consulting platform as an evolution to their RCO delivery model. By enhancing ProPharma's global RCO capability with AI and machine learning solutions, Prodigy bolsters ProPharma's ability to lead the industry in its journey from volume to value, where access to information, and the utility of technology and evidence continue to drive increased nuance and opportunity for innovators. This innovative development underscores ProPharma's commitment to driving change in the clinical research industry, with a focus on becoming an insights leader and providing friction-free and insightful experiences for their clients.

Key Points: 
  • ProPharma Group has introduced Prodigy, an end-to-end technology-enabled consulting platform as an evolution to their RCO delivery model.
  • Prodigy is a result of ProPharma's strategic investment of over $5 million in 2023 alone, reflecting the company's dedication to innovation in the life sciences industry.
  • In particular, ProPharma has integrated a large language model construct into the platform, Prodigy GPT, which enables advanced knowledge management and information processing.
  • The whitepaper dives into how ProPharma's Prodigy platform addresses shortcomings of the CRO model with the new tech-enabled consulting platform.

Recovery Community Organization Certification Program Launches in Washington, D.C.

Retrieved on: 
金曜日, 12月 29, 2023

WASHINGTON, Dec. 29, 2023 /PRNewswire-PRWeb/ -- In a landmark initiative to further empower and legitimize organizations committed to supporting recovery from substance use and co-occurring disorders, Faces & Voices of Recovery is proud to introduce its Recovery Community Organization (RCO) Certification Program. This program recognizes and certifies organizations that champion the cause of recovery and provide essential support to individuals, families, and communities affected by addiction.

Key Points: 
  • Faces & Voices of Recovery launches a new Certification Program for Recovery Community Organizations.
  • WASHINGTON, Dec. 29, 2023 /PRNewswire-PRWeb/ -- In a landmark initiative to further empower and legitimize organizations committed to supporting recovery from substance use and co-occurring disorders, Faces & Voices of Recovery is proud to introduce its Recovery Community Organization (RCO) Certification Program.
  • This certification program recognizes organizations that champion recovery and support individuals, families, and communities affected by addiction.
  • The RCO Certification Program has been shaped by conversations with stakeholders, subject-matter experts, and members of The Alliance for Recovery Centered Organizations .